Cancel
Known information
- Founded several biotechnology companies including Xanadu Bio and Gennao Bio
- Served as Chief Executive Officer and President at Xanadu Bio and Gennao Bio
- Successfully raised more than $100M of financing for his companies
- Spent 5 years at Hoffman La-Roche in drug development for metabolic diseases and oncology
- Was a managing director at Boxer Capital of the Tavistock Group and Bank of America Merrill Lynch
- Author of more than 40 publications primarily in areas of breast cancer and signal transduction
- Completed undergraduate education at the University of Chicago
- Graduated from University of Pennsylvania School of Medicine with M.D and Ph.D. degrees
- Completed a residency in Radiation Oncology at Yale University
About Immunome
Immunome is a biotechnology company focused on developing innovative cancer therapies, including immunotherapies and targeted treatments, using its proprietary memory B cell hybridoma technology.
Report inaccurate information
